T cell response in patients with COVID-19

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a significant global health threat, causing Coronavirus Disease 2019 (COVID-19).
• SARS-CoV-2 shares genetic similarities with other zoonotic coronaviruses like SARS-CoV and MERS-CoV.
• COVID-19, particularly in severe cases, is associated with acute tissue damage driven by an aberrant immune response.

Purpose of the Study:

• To summarize dynamic changes in T cell count, subsets, phenotype, and function in COVID-19 patients.
• To enhance understanding of the pathological immune response involving T cells during SARS-CoV-2 infection.
• To facilitate the development of improved therapeutic strategies for COVID-19.

Main Methods:

• Review of current clinical reports and literature on T cell dynamics in COVID-19 patients.
• Analysis of data concerning T cell count, subsets (e.g., CD4+, CD8+), phenotype, and functional characteristics.
• Synthesis of findings to elucidate the role of T cells in SARS-CoV-2 pathogenesis.

Main Results:

• Dynamic alterations in T cell counts and subsets are observed in COVID-19 patients.
• Changes in T cell phenotype and function contribute to the pathological immune response in severe cases.
• T cell responses are critical for viral clearance and disease progression in SARS-CoV-2 infection.

Conclusions:

• Understanding T cell dynamics is crucial for comprehending the immune pathology of COVID-19.
• The review provides insights that can guide the development of targeted immunotherapies for SARS-CoV-2 infection.
• Further research into T cell responses may lead to more effective treatments for Coronavirus Disease 2019.